Fatigue and excessive daytime sleepiness in idiopathic Parkinson’s disease differently correlate with motor symptoms, depression and dopaminergic treatment
Identifieur interne : 000717 ( Main/Exploration ); précédent : 000716; suivant : 000718Fatigue and excessive daytime sleepiness in idiopathic Parkinson’s disease differently correlate with motor symptoms, depression and dopaminergic treatment
Auteurs : P. O. Valko ; D. Waldvogel ; M. Weller ; C. L. Bassetti [Suisse] ; U. Held ; C. R. BaumannSource :
- European Journal of Neurology [ 1351-5101 ] ; 2010-12.
English descriptors
- KwdEn :
Abstract
Background and purpose: A comprehensive study of both fatigue and excessive daytime sleepiness (EDS) in association with Parkinson’s disease (PD)‐related symptoms and treatment has not been performed yet. To assess the frequency and severity of fatigue and EDS in patients with idiopathic PD and to study their relation to motor and non‐motor symptoms and dopaminergic treatment. Methods: We prospectively assessed Fatigue Severity Scale (FSS) scores, Epworth Sleepiness Scale (ESS) scores, Beck Depression Inventory (BDI) scores, severity (Unified PD Rating Scale, UPDRS, part III; Hoehn & Yahr staging) and duration of the disease, and the current dopaminergic treatment in 88 consecutive patients with idiopathic PD. Results: Fatigue was found in 52 (59%), EDS in 42 (48%), and both complaints in 31 (35%) patients. Fatigued patients had higher UPDRS III scores (23.5 ± 11.1 vs. 18.6 ± 7.6, P = 0.03), higher Hoehn & Yahr staging (2.4 ± 0.9 vs. 2.1 ± 0.7, P = 0.03), and higher BDI scores (13.4 ± 7.1 vs. 9.1 ± 5.8, P = 0.004) than non‐fatigued patients. In contrast, UPDRS III, Hoehn & Yahr, and BDI scores did not differ between patients with or without EDS. However, the type of dopaminergic treatment (levodopa monotherapy versus combination of levodopa/dopamine agonists) was associated with significant differences in ESS (8.5 ± 5.2 vs. 10.8 ± 4.3, P = 0.04), but not FSS scores (4.1 ± 1.5 vs. 4.3 ± 1.5, P = 0.55). Disease duration correlated with ESS scores (r = 0.32, P = 0.003), but not with FSS scores (r = −0.02, P = 0.82). Conclusions: In PD, there is a significant overlap of fatigue and EDS, but the two symptoms are differently correlated with the severity of motor symptoms, disease duration, depression, and dopaminergic treatment.
Url:
DOI: 10.1111/j.1468-1331.2010.03063.x
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Fatigue and excessive daytime sleepiness in idiopathic Parkinson’s disease differently correlate with motor symptoms, depression and dopaminergic treatment</title><author><name sortKey="Valko, P O" sort="Valko, P O" uniqKey="Valko P" first="P. O." last="Valko">P. O. Valko</name></author><author><name sortKey="Waldvogel, D" sort="Waldvogel, D" uniqKey="Waldvogel D" first="D." last="Waldvogel">D. Waldvogel</name></author><author><name sortKey="Weller, M" sort="Weller, M" uniqKey="Weller M" first="M." last="Weller">M. Weller</name></author><author><name sortKey="Bassetti, C L" sort="Bassetti, C L" uniqKey="Bassetti C" first="C. L." last="Bassetti">C. L. Bassetti</name></author><author><name sortKey="Held, U" sort="Held, U" uniqKey="Held U" first="U." last="Held">U. Held</name></author><author><name sortKey="Baumann, C R" sort="Baumann, C R" uniqKey="Baumann C" first="C. R." last="Baumann">C. R. Baumann</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:6206A2ABB7F6683BD83D5673119E9D298BDBFBF6</idno><date when="2010" year="2010">2010</date><idno type="doi">10.1111/j.1468-1331.2010.03063.x</idno><idno type="url">https://api.istex.fr/document/6206A2ABB7F6683BD83D5673119E9D298BDBFBF6/fulltext/pdf</idno><idno type="wicri:Area/Main/Corpus">000445</idno><idno type="wicri:Area/Main/Curation">000385</idno><idno type="wicri:Area/Main/Exploration">000717</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Fatigue and excessive daytime sleepiness in idiopathic Parkinson’s disease differently correlate with motor symptoms, depression and dopaminergic treatment</title><author><name sortKey="Valko, P O" sort="Valko, P O" uniqKey="Valko P" first="P. O." last="Valko">P. O. Valko</name><affiliation><wicri:noCountry code="no comma">Department of Neurology</wicri:noCountry></affiliation></author><author><name sortKey="Waldvogel, D" sort="Waldvogel, D" uniqKey="Waldvogel D" first="D." last="Waldvogel">D. Waldvogel</name><affiliation><wicri:noCountry code="no comma">Department of Neurology</wicri:noCountry></affiliation></author><author><name sortKey="Weller, M" sort="Weller, M" uniqKey="Weller M" first="M." last="Weller">M. Weller</name><affiliation><wicri:noCountry code="no comma">Department of Neurology</wicri:noCountry></affiliation></author><author><name sortKey="Bassetti, C L" sort="Bassetti, C L" uniqKey="Bassetti C" first="C. L." last="Bassetti">C. L. Bassetti</name><affiliation><wicri:noCountry code="no comma">Department of Neurology</wicri:noCountry></affiliation><affiliation wicri:level="1"><country xml:lang="fr">Suisse</country><wicri:regionArea>Neurocenter of Southern Switzerland, Lugano</wicri:regionArea><wicri:noRegion>Lugano</wicri:noRegion></affiliation></author><author><name sortKey="Held, U" sort="Held, U" uniqKey="Held U" first="U." last="Held">U. Held</name><affiliation><wicri:noCountry code="subField">Zurich:</wicri:noCountry></affiliation></author><author><name sortKey="Baumann, C R" sort="Baumann, C R" uniqKey="Baumann C" first="C. R." last="Baumann">C. R. Baumann</name><affiliation><wicri:noCountry code="no comma">Department of Neurology</wicri:noCountry></affiliation></author></analytic><monogr></monogr><series><title level="j">European Journal of Neurology</title><idno type="ISSN">1351-5101</idno><idno type="eISSN">1468-1331</idno><imprint><publisher>Blackwell Publishing Ltd</publisher><pubPlace>Oxford, UK</pubPlace><date type="published" when="2010-12">2010-12</date><biblScope unit="volume">17</biblScope><biblScope unit="issue">12</biblScope><biblScope unit="page" from="1428">1428</biblScope><biblScope unit="page" to="1436">1436</biblScope></imprint><idno type="ISSN">1351-5101</idno></series><idno type="istex">6206A2ABB7F6683BD83D5673119E9D298BDBFBF6</idno><idno type="DOI">10.1111/j.1468-1331.2010.03063.x</idno><idno type="ArticleID">ENE3063</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">1351-5101</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>depression</term><term>disease duration</term><term>dopaminergic treatment</term><term>excessive daytime sleepiness</term><term>fatigue</term><term>idiopathic Parkinson’s disease</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Background and purpose: A comprehensive study of both fatigue and excessive daytime sleepiness (EDS) in association with Parkinson’s disease (PD)‐related symptoms and treatment has not been performed yet. To assess the frequency and severity of fatigue and EDS in patients with idiopathic PD and to study their relation to motor and non‐motor symptoms and dopaminergic treatment. Methods: We prospectively assessed Fatigue Severity Scale (FSS) scores, Epworth Sleepiness Scale (ESS) scores, Beck Depression Inventory (BDI) scores, severity (Unified PD Rating Scale, UPDRS, part III; Hoehn & Yahr staging) and duration of the disease, and the current dopaminergic treatment in 88 consecutive patients with idiopathic PD. Results: Fatigue was found in 52 (59%), EDS in 42 (48%), and both complaints in 31 (35%) patients. Fatigued patients had higher UPDRS III scores (23.5 ± 11.1 vs. 18.6 ± 7.6, P = 0.03), higher Hoehn & Yahr staging (2.4 ± 0.9 vs. 2.1 ± 0.7, P = 0.03), and higher BDI scores (13.4 ± 7.1 vs. 9.1 ± 5.8, P = 0.004) than non‐fatigued patients. In contrast, UPDRS III, Hoehn & Yahr, and BDI scores did not differ between patients with or without EDS. However, the type of dopaminergic treatment (levodopa monotherapy versus combination of levodopa/dopamine agonists) was associated with significant differences in ESS (8.5 ± 5.2 vs. 10.8 ± 4.3, P = 0.04), but not FSS scores (4.1 ± 1.5 vs. 4.3 ± 1.5, P = 0.55). Disease duration correlated with ESS scores (r = 0.32, P = 0.003), but not with FSS scores (r = −0.02, P = 0.82). Conclusions: In PD, there is a significant overlap of fatigue and EDS, but the two symptoms are differently correlated with the severity of motor symptoms, disease duration, depression, and dopaminergic treatment.</div></front></TEI><affiliations><list><country><li>Suisse</li></country></list><tree><noCountry><name sortKey="Baumann, C R" sort="Baumann, C R" uniqKey="Baumann C" first="C. R." last="Baumann">C. R. Baumann</name><name sortKey="Held, U" sort="Held, U" uniqKey="Held U" first="U." last="Held">U. Held</name><name sortKey="Valko, P O" sort="Valko, P O" uniqKey="Valko P" first="P. O." last="Valko">P. O. Valko</name><name sortKey="Waldvogel, D" sort="Waldvogel, D" uniqKey="Waldvogel D" first="D." last="Waldvogel">D. Waldvogel</name><name sortKey="Weller, M" sort="Weller, M" uniqKey="Weller M" first="M." last="Weller">M. Weller</name></noCountry><country name="Suisse"><noRegion><name sortKey="Bassetti, C L" sort="Bassetti, C L" uniqKey="Bassetti C" first="C. L." last="Bassetti">C. L. Bassetti</name></noRegion></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000717 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000717 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= ParkinsonV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= ISTEX:6206A2ABB7F6683BD83D5673119E9D298BDBFBF6
|texte= Fatigue and excessive daytime sleepiness in idiopathic Parkinson’s disease differently correlate with motor symptoms, depression and dopaminergic treatment
}}
| This area was generated with Dilib version V0.6.23. |  |